Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of Phase IIa Trial

Gastroenterology. 2021 Jun;160(7):2595-2598.e3. doi: 10.1053/j.gastro.2021.02.054. Epub 2021 Mar 2.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Anti-Inflammatory Agents / administration & dosage*
  • Colitis, Ulcerative / drug therapy*
  • Colitis, Ulcerative / pathology
  • Double-Blind Method
  • Female
  • Follow-Up Studies
  • Humans
  • Induction Chemotherapy / methods*
  • Male
  • Middle Aged
  • Quinolines / administration & dosage*
  • Severity of Illness Index
  • Treatment Outcome

Substances

  • ABX464
  • Anti-Inflammatory Agents
  • Quinolines